RANTES Gene Polymorphisms and Asthma Risk: A Meta-Analysis

Archives of Medical Research

Volumn 41, Issue 1, 2010, Pages 50-58

  Zhang, Yong Gang ^a   Huang, Jin ^b   Zhang, Jie ^c   Li, Xiao Bo ^a   He, Chao ^a   Xiao, Yu Ling ^a   Tian, Can ^a   Wan, Hua ^a   Zhao, Yu Liang ^a   Tsewang, Yangzom Ghising ^a   Fan, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b Chinese Evidence Based Medicine/Cochrane Center   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

AFRICAN AMERICAN; AGE; ALLERGIC ASTHMA; ARTICLE; ASIAN; ASTHMA; ETHNICITY; EUROPEAN; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; RISK FACTOR;

ASTHMA; CASE-CONTROL STUDIES; CHEMOKINE CCL5; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC;

EID: 77952302198     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.01.002     Document Type: Article

References (30)

1. Richter M., Cantin A.M., Beaulieu C., et al. Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003, 285:L719-L729.
2. Rojas-Ramos E., Avalos A.F., Perez-Fernandez L., et al. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and-4, and eotaxins-1 and-2 in childhood asthma. Eur Respir J 2003, 22:310-316.
3. Penido C., Castro-Faria-Neto H.C., Vieira-de-Abreu A., et al. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and eotaxin. Am J Resp Cell Mol 2001, 25:707-716.
4. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax 1999, 54:825-857.
5. Berkman N., Krishnan V.L., Gilbey T., et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 1996, 154:1804-1811.
6. Powell N., Humbert M., Durham S.R., et al. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 1996, 9:2454-2460.
7. Zietkowski Z., Tomasiak M.M., Skiepko R., et al. RANTES in exhaled breath condensate of stable and unstable asthma patients. Respir Med 2008, 102:1198-1202.
8. Lachheb J., Chelbi H., Hamzaoui K., et al. Association between RANTES polymorphisms and asthma severity among Tunisian children. Hum Immunol 2007, 68:675-680.
9. Fryer A.A., Spiteri M.A., Bianco A., et al. The -403 G->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000, 1:509-514.
10. Muro M., Marin L., Torio A., et al. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenet 2008, 35:19-23.
11. Thakkinstian A., McEvoy M., Minelli C., et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
12. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
13. Egger M., Davey S.G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
14. Al-Abdulhadi S.A., Helms P.J., Main M., et al. Preferential transmission and association of the -403 G -> A promoter RANTES polymorphism with atopic asthma. Genes Immun 2005, 6:24-30.
15. Hizawa N., Yamaguchi E., Konno S., et al. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med 2002, 166:686-690.
16. Liu M., Li H.L., Huang Y.K., et al. The SNPs of chemokine RANTES promoter in children with asthma (Chinese). Zhong Guo You Sheng Yu Yi Chuan Za Zhi 2005, 13:20-24.
17. Moissidis I., Chinoy B., Yanamandra K., et al. Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genet Med 2005, 7:406-410.
18. Sohn M.H., Kim S.H., Kim K.W., et al. RANTES gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korean children with asthma. Lung 2008, 186:37-43.
19. Szalai C., Kozma G.T., Nagy A., et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001, 108:375-381.
20. Tolgyesi G., Keszei M., Ungvari I., et al. Involvement of TNFα -308A promoter polymorphism in the development of asthma in children infected with Chlamydophila pneumoniae. Pediatr Res 2006, 60:543-548.
21. Wang L.J., Li Y.R., Chen J.H., et al. Polymorphism of regulated upon activation, normal T cell expressed and secreted promoter region -28 position in Chinese allergic asthmatic children (Chinese). Zhonghua Jie He He Hu Xi Za Zhi 2004, 27:394-397.
22. Yao T.C., Kuo M.L., See L.C., et al. The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 2003, 111:1285-1292.
23. Tanaka K., Roberts M.H., Yamamoto N., et al. Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis. Int J Immunogenet 2006, 33:423-428.
24. Qiu L.X., Li R.T., Zhang J.B., et al. The E-cadherin (CDH1)-160 C/A polymorphism and prostate cancer risk: a meta-analysis. Eur J Hum Genet 2009, 17:244-249.
25. Kato Y., Pawankar R., Kimura Y., et al. Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema. Int Arch Allergy Immunol 2006, 139:245-257.
26. Bai B.X., Tanaka K., Tazawa T., et al. Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci 2005, 39:189-191.
27. Yao T.C., Tsai Y.C., Huang J.L. Association of RANTES promoter polymorphism with juvenile rheumatoid arthritis. Arthritis Rheum 2009, 60:1173-1178.
28. Mlynarski W.M., Placha G.P., Wolkow P.P., et al. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5)-A sex-specific effect. Diabetes 2005, 54:3331-3335.
29. Herder C., Illig T., Baumert J., et al. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol 2008, 158:R1-R5.
30. Saenz-Lopez P., Carretero R., Cozar J.M., et al. Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer 2008, 8:382.